Westchester Capital Management (New York)’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Westchester Capital Management (New York)’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-405,863	Closed	-$27.6M	–	610
2022 Q3	$27.6M	Buy	+405,863	New	+$22.4M	0.78%	26

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Westchester Capital Management (New York)'s GBT Position: Q4 2022 in Review

Westchester Capital Management (New York) sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 405,863 shares — an estimated $27.6M sold.

Westchester Capital Management (New York) first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $27.6M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Westchester Capital Management (New York) reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Westchester Capital Management (New York) sold 405,863 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $27.6M.
Westchester Capital Management (New York) first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
Westchester Capital Management (New York)'s Global Blood Therapeutics, Inc. position peaked at $27.6M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.